down arrow

Shanghai Fudan Zhangjiang Bio Pharmaceutical Co., Ltd.

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE1000000W4
HKD
2.67
-0.41 (-13.31%)

Sep 23

HKG

 View all stocks in this country
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Jun'26
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Net Sales
256.88
168.19
147.78
175.92
226.78
192.35
173.63
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
256.88
168.19
147.78
175.92
226.78
192.35
173.63
Raw Material Cost
35.94
27.79
28.47
29.43
38.54
29.99
31.67
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.14
0.15
0.15
0.17
0.18
0.22
0.18
Selling and Distribution Expenses
104.32
89.53
138.81
109.81
100.40
82.52
126.52
Other Expenses
8.34
5.02
11.54
6.26
9.26
8.12
7.51
Total Expenditure (Excl Depreciation)
223.84
167.66
282.83
202.05
231.70
193.91
233.49
Operating Profit (PBDIT) excl Other Income
33
0.5
-135
-26.099999999999998
-4.9
-1.6
-59.900000000000006
Other Income
5.35
13.36
6.85
8.91
11.36
7.84
6.58
Operating Profit (PBDIT)
57.94
31.98
-110.92
-0.20
26.39
27.16
-35.38
Interest
0.14
0.15
0.15
0.17
0.18
0.22
0.18
Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
220.94
140.40
119.31
146.49
188.23
162.36
141.96
Depreciation
21.56
21.14
20.25
20.17
22.52
22.31
25.95
Profit Before Tax
36.25
10.69
-131.32
-20.54
3.69
4.63
-61.51
Tax
0.00
0.00
2.05
0.00
0.00
0.00
-34.33
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
33.59
8.70
-155.22
-23.66
3.29
2.85
-50.54
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
33.59
8.70
-155.22
-23.66
3.29
2.85
-50.54
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-0.04
-0.09
-0.10
-0.11
-0.01
-0.09
-0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
33.55
8.62
-155.31
-23.77
3.28
2.76
-50.54
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.12
0.11
0.11
0.11
0.11
0.11
0.11
Reserves
2,487.90
2,410.23
2,357.16
2,468.26
2,497.61
2,475.38
2,452.55
Earnings per share (EPS)
0.03
0.01
-0.15
-0.02
0.0
0.0
-0.05
Diluted Earnings per share
0.03
0.01
-0.15
-0.02
0.0
0.0
-0.05
Operating Profit Margin (Excl OI)
12.08%
-1.5%
-93.39%
-16.64%
-3.3%
-1.55%
-39.11%
Gross Profit Margin
22.5%
18.92%
-75.16%
-0.21%
11.56%
14.01%
-20.48%
PAT Margin
13.08%
5.17%
-105.03%
-13.45%
1.45%
1.48%
-29.11%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Jun 2026 is 52.73% vs 13.80% in Mar 2026

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Jun 2026 is 289.53% vs 105.54% in Mar 2026

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Jun 2026 is 182.80% vs 115.79% in Mar 2026

stock-summary

Interest

QoQ Growth in quarter ended Jun 2026 is 0.00% vs -50.00% in Mar 2026

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Jun 2026 has improved from Mar 2026

Compare Quarterly Results Of Shanghai Fudan Zhangjiang Bio Pharmaceutical Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(HKD)
Change(%)
Net Sales
256.88
1,437.25
-1,180.37
-82.13%
Other Operating Income
0.00
0.00
0.00
Total Operating income
256.88
1,437.25
-1,180.37
-82.13%
Raw Material Cost
35.94
972.05
-936.11
-96.30%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
0.14
14.54
-14.40
-99.04%
Selling and Distribution Expenses
104.32
258.54
-154.22
-59.65%
Other Expenses
8.34
3.59
4.75
132.31%
Total Expenditure (Excl Depreciation)
223.84
1,281.04
-1,057.20
-82.53%
Operating Profit (PBDIT) excl Other Income
33.04
156.21
-123.17
-78.85%
Other Income
5.35
-23.30
28.65
122.96%
Operating Profit (PBDIT)
57.94
230.22
-172.28
-74.83%
Interest
0.14
14.54
-14.40
-99.04%
Exceptional Items
0.00
-9.03
9.03
100.00%
Gross Profit (PBDT)
220.94
465.20
-244.26
-52.51%
Depreciation
21.56
110.31
-88.75
-80.46%
Profit Before Tax
36.25
96.35
-60.10
-62.38%
Tax
0.00
-16.89
16.89
100.00%
Provisions and contingencies
0
0
0.00
Profit After Tax
33.59
100.96
-67.37
-66.73%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
33.59
100.96
-67.37
-66.73%
Share in Profit of Associates
0
0
0.00
Minority Interest
-0.04
-0.22
0.18
81.82%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
33.55
100.74
-67.19
-66.70%
Equity Capital
0
0
0.00
Face Value
0.12
1.16
0.00
Reserves
2,487.90
13,792.23
-11,304.33
-81.96%
Earnings per share (EPS)
0.03
0.07
-0.04
-57.14%
Diluted Earnings per share
0.03
0.07
-0.04
-57.14%
Operating Profit Margin (Excl OI)
12.08%
9.96%
0.00
2.12%
Gross Profit Margin
22.50%
14.38%
0.00
8.12%
PAT Margin
13.08%
7.02%
0.00
6.06%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 25.69 Million
in Jun 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2026 is 52.73% vs 13.80% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is 13.27% vs -18.86% in Jun 2025

Quarterly - Consolidate Net Profit
Consolidate Net Profit 3.35 Million
in Jun 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2026 is 289.53% vs 105.54% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is 915.15% vs -95.51% in Jun 2025

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 5.26 Million
in Jun 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2026 is 182.80% vs 115.79% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is 250.67% vs -79.59% in Jun 2025

Quarterly - Interest
Interest 0.01 Million
in Jun 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2026 is 0.00% vs -50.00% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is -50.00% vs 100.00% in Jun 2025

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 12.08%
in Jun 2026

Figures in %
stock-summary

QoQ Growth in quarter ended Jun 2026 has improved from Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 has improved from Jun 2025

Footer loading